Science & Health

As a graduate student, Rob Devlin PhD ’17 helped develop an innovative mini-lens. Now he runs a startup that produces millions of the devices for use in an array of consumer electronics.

Three Harvard Medical School research teams received Blavatnik Therapeutics Challenge Awards to pursue novel approaches to medical challenges, offering potential solutions to people affected by Fragile X syndrome, oxygen deprivation, and Parkinson’s disease.

A biotechnology startup launched out of a Harvard chemistry lab is developing new antibiotic compounds that show promise in treating drug-resistant infections and diseases.

Harvard Medical School researchers paired a genetic insight with gene editing technology to create a life-changing new therapy for sickle cell disease.

John H. Shaw, Harvard's vice provost for research, explains the crucial role of NIH support for biomedical research at the University.

In a small clinical trial led by Harvard Medical School researchers, a personalized vaccine generated robust immune response in patients with advanced kidney cancer.

The AI cluster at Harvard's Kempner Institute for the Study of Natural and Artificial Intelligence has been ranked as one of the fastest and greenest supercomputers on the planet.

In an unprecedented collective scientific effort, researchers from Harvard and three other universities have launched a 10-year study of the Los Angeles fires.

The Harvard Move Lab has developed a wearable robotic device aimed at helping stroke survivors and people with other movement impairments regain mobility and independence. 

Harvard scientists developed a slug-inspired adhesive for dental care, which soon may be the answer to managing painful oral lesions associated with chronic inflammatory conditions and sealing wounds in the mouth.